‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.Allergic rhinitis and COVID-19: advice for pharmacists
At a time when it is vital to identify and treat individuals infected with the COVID-19 virus, it is also important to recognise and manage the symptoms of allergic rhinitis.
Diethylstilbestrol: a public health disaster
A multi-use artificial hormone, Diethylstilbestrol was controversial from its discovery, with the inventor of the drug warning of possible side effects. Its impact on...
Aggression ramps up in pharmacies as fear increases
Aggressive consumers wanting quantities of ‘just in case’ medicines amid COVID-19 panic has added considerably to workplace stress.
‘We’re saving lives’: naloxone pilot prevents three deaths per day
Pharmacists discuss the impressive results of the Take Home Naloxone Pilot and why subsidised access to the medicine is a must going forward.
The story of lithium and mental health
Lithium is an invaluable and lifesaving treatment for a range of psychiatric disorders, but its origins lie in patent medicine and the pioneering work...
AstraZeneca COVID-19 vaccine and clotting: what to watch for
An expert panel has confirmed a second case of thrombosis with thrombocytopenia in Australia is likely linked to AstraZeneca’s COVID-19 vaccine.
